Andrew Dunbar, general manager for EMEA at global digital consultancy, Appnovation, explores the core principles of data analytics and how pharma firms can benefit from this data revolution.
Covid-19 has accelerated digital transformation across most sectors of society, forcing companies to immediately adopt new processes they had planned to introduce incrementally over months or years. For pharma firms seeking to emerge stronger from this paradigm shift, it’s vital to adopt a smart approach to data analytics.
The irreversible transition towards a digitally-powered society and economy was on its way long before Covid-19 struck. But there’s no question that the restrictions enforced by this pitiless pandemic have accelerated that process – often by years.